OraSure Technologies | OSUR - Sales Revenues


OraSure Technologies reported $26.76M in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Agilent USD 1.8B 63M Dec/2025
AngioDynamics USD 79.43M 3.72M Sep/2025
Becton, Dickinson and Co. USD 5.3B 600M Dec/2025
Bio Techne USD 295.9M 9.34M Dec/2025
Bio-Rad Laboratories USD 693.2M 40.2M Dec/2025
Bruker USD 977.2M 116.7M Dec/2025
Cerus USD 50.81M 4.79M Dec/2024
Charles River Laboratories USD 994.2M 5.8M Dec/2025
Danaher USD 6.84B 790M Dec/2025
Dentsply International USD 961M 57M Dec/2025
Dexcom USD 1.26B 50M Dec/2025
Illumina USD 1.16B 80M Dec/2025
Integra LifeSciences USD 434.9M 32.84M Dec/2025
Intuitive Surgical USD 2.87B 360M Dec/2025
IQVIA Holdings USD 4.36B 260M Dec/2025
Mesa Laboratories USD 62.84M 5.01M Dec/2024
Mettler Toledo International USD 1.13B 100M Dec/2025
Myriad Genetics USD 209.8M 4.1M Dec/2025
OraSure Technologies USD 26.76M 322K Dec/2025
Quidel USD 724M 24M Dec/2025
Repligen USD 197.91M 8.91M Dec/2025
Revvity USD 772.06M 73.06M Dec/2025
STAAR Surgical USD 239.4M 144.7M Dec/2025
Thermo Fisher Scientific USD 12.21B 1.09B Dec/2025
Trinity Biotech USD 14.31M 1.55M Sep/2025
Waters USD 932M 132M Dec/2025